915 related articles for article (PubMed ID: 31669213)
1. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in nanocarrier-aided mucosal vaccination.
Kammona O; Bourganis V; Karamanidou T; Kiparissides C
Nanomedicine (Lond); 2017 May; 12(9):1057-1074. PubMed ID: 28440707
[TBL] [Abstract][Full Text] [Related]
3. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
Sharma R; Agrawal U; Mody N; Vyas SP
Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
[TBL] [Abstract][Full Text] [Related]
4. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
[TBL] [Abstract][Full Text] [Related]
6. The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.
Davis SS
Vaccine; 2006 Apr; 24 Suppl 2():S2-7-10. PubMed ID: 16823907
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers for systemic and mucosal vaccine delivery.
Shahiwala A; Vyas TK; Amiji MM
Recent Pat Drug Deliv Formul; 2007; 1(1):1-9. PubMed ID: 19075870
[TBL] [Abstract][Full Text] [Related]
8. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulators and delivery systems for vaccination by mucosal routes.
Ryan EJ; Daly LM; Mills KH
Trends Biotechnol; 2001 Aug; 19(8):293-304. PubMed ID: 11451471
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery.
Mehrabi M; Montazeri H; Mohamadpour Dounighi N; Rashti A; Vakili-Ghartavol R
Arch Razi Inst; 2018 Sep; 73(3):165-176. PubMed ID: 30280836
[TBL] [Abstract][Full Text] [Related]
11. Mucosal vaccine design and delivery.
Woodrow KA; Bennett KM; Lo DD
Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
[TBL] [Abstract][Full Text] [Related]
12. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
13. Novel vaccine development strategies for inducing mucosal immunity.
Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
[TBL] [Abstract][Full Text] [Related]
14. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
15. Nasal and pulmonary vaccine delivery using particulate carriers.
Jia Y; Krishnan L; Omri A
Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
[TBL] [Abstract][Full Text] [Related]
17. Rational application of nanoadjuvant for mucosal vaccine delivery system.
Dewangan HK
J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
[TBL] [Abstract][Full Text] [Related]
18. Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers.
Garg NK; Mangal S; Khambete H; Tyagi RK
Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):114-28. PubMed ID: 20380624
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori vaccine: mucosal adjuvant & delivery systems.
Sijun H; Yong X
Indian J Med Res; 2009 Aug; 130(2):115-24. PubMed ID: 19797807
[TBL] [Abstract][Full Text] [Related]
20. Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.
Bolhassani A; Javanzad S; Saleh T; Hashemi M; Aghasadeghi MR; Sadat SM
Hum Vaccin Immunother; 2014; 10(2):321-32. PubMed ID: 24128651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
